Reports
Sale
Middle East and Africa Intravenous Solutions Market: Share, Size, Trends, Analysis: By Type: Partial Parenteral Nutrition, Total Parenteral Nutrition; By Nutrients: Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids; Regional Analysis; Market Dynamics; Competitive Landscape; Industry Events and Developments; 2024-2032
Middle East and Africa Intravenous Solutions Market Outlook
The Middle East and Africa intravenous solutions market is expected to grow at a CAGR of 6.7% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Intravenous solutions or intravenous fluids are described as supplemental fluids employed in intravenous therapy. They are used to maintain or restore the normal volume of fluids in a person along with balancing electrolytes when there is no possibility for an oral route. The therapy is an effective and efficient method of providing fluids promptly while controlling electrolyte losses, as well as in managing treatments along with blood products.
- With an increase in natality rates, rising geriatric population, and surging prevalence of cancer, the intravenous solutions market in the Middle East and Africa region is expected to gain momentum in the coming years.
- An increase in the prevalence of malnutrition along with growing healthcare expenditure is further expected to boost the market growth of intravenous solutions over the upcoming years.
- The higher efficacy and faster response time related to IV solution therapy are promoting the growth of the Middle East and Africa intravenous solutions market.
- Market Opportunities and Challenges
- The surging investments by health agencies of various countries in the healthcare industry are expected to create market opportunities during the forecast period.
- Going further, the surging participation of individuals in physical activities is further expected to push forward the adoption of intravenous solutions for faster recoveries.
- The possible side effects of IV medication which can be both mild and dangerous like allergic reactions are likely to hamper the demand in the Middle East and Africa intravenous solutions market.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market can be segmented into partial parenteral nutrition and total parenteral nutrition. Based on nutrients, the market can be divided into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. On the basis of countries, the market can be divided into Saudi Arabia, the United Arab Emirates, Kuwait, Algeria, Nigeria, Kenya, Morocco, and South Africa, among others.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Middle East and Africa Intravenous Solutions market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Becton, Dickinson and Company
- Fresenius Kabi South Africa (Pty) Ltd
- Well Pharma Medical Solutions LLC
- Alpha Medical Manufacturers Limited
- Intravenous Infusions Plc
- Others
Market Share by Type
The total parenteral nutrition segment is expected to hold significant growth in the intravenous solutions market share during the forecast period on account of the increase in gastrointestinal diseases, like Crohn’s Disease and Ulcerative Colitis. In such conditions, patients are not able to absorb or retain crucial nutrients, and thereby, such crucial nutrients are delivered via an intravenous route. With an increase in the geriatric population, the demand for the segment is growing during the forecast period across the market as the patients require crucial nutrients through intravenous routes.
Market Share by Nutrient
The amino acid segment is expected to gain momentum in the Middle East and Africa intravenous solutions market share on account of the rise in the number of cancer patients. Going further, the increasing adoption of unhealthy lifestyles along with evolving technology is further expected to influence the segment growth in the market over the upcoming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
- Becton, Dickinson, and Company is a world leading medical technology enterprise involved in the development, manufacture, and sale of a variety of medical devices, diagnostic products, laboratory equipment, and supplies. It operates with three primary business segments which are BD Life Sciences, BD Interventional, and BD Medical.
- Fresenius Kabi South Africa (Pty) Ltd is a leading healthcare company. The company specialises in lifesaving technologies and medicines for transfusion, clinical nutrition, and infusion. Its services and products are used for chronically and critically ill patients.
- Well Pharma Medical Solutions LLC is the United Arab Emirates' first and only IV solutions producing plant catering to the ever-growing demand for life-saving IV solutions in DEHP-free containers and bags.
Other market players include Alpha Medical Manufacturers Limited and Intravenous Infusions Plc, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Nutrients |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Global Intravenous Solutions Market Overview
8.1 Key Industry Highlights
8.2 Global Intravenous Solutions Historical Market (2018-2023)
8.3 Global Intravenous Solutions Market Forecast (2024-2032)
8.4 Global Intravenous Solutions Market by Region
8.4.1 Market Share
8.4.1.1 North America
8.4.1.2 Europe
8.4.1.3 Asia Pacific
8.4.1.4 Latin America
8.4.1.5 Middle East and Africa
9 Middle East and Africa Intravenous Solutions Market Analysis
9.1 Key Industry Highlights
9.2 Middle East and Africa Intravenous Solutions Historical Market (2018-2023)
9.3 Middle East and Africa Intravenous Solutions Market Forecast (2024-2032)
9.4 Middle East and Africa Intravenous Solutions Market by Type
9.4.1 Partial Parenteral Nutrition
9.4.1.1 Market Share
9.4.1.2 Historical Trend (2018-2023)
9.4.1.3 Forecast Trend (2024-2032)
9.4.2 Total Parenteral Nutrition
9.4.2.1 Market Share
9.4.2.2 Historical Trend (2018-2023)
9.4.2.3 Forecast Trend (2024-2032)
9.5 Middle East and Africa Intravenous Solutions Market by Nutrients
9.5.1 Carbohydrates
9.5.1.1 Market Share
9.5.1.2 Historical Trend (2018-2023)
9.5.1.3 Forecast Trend (2024-2032)
9.5.2 Salts and Electrolytes
9.5.2.1 Market Share
9.5.2.2 Historical Trend (2018-2023)
9.5.2.3 Forecast Trend (2024-2032)
9.5.3 Minerals
9.5.3.1 Market Share
9.5.3.2 Historical Trend (2018-2023)
9.5.3.3 Forecast Trend (2024-2032)
9.5.4 Vitamins
9.5.4.1 Market Share
9.5.4.2 Historical Trend (2018-2023)
9.5.4.3 Forecast Trend (2024-2032)
9.5.5 Amino Acids
9.5.5.1 Market Share
9.5.5.2 Historical Trend (2018-2023)
9.5.5.3 Forecast Trend (2024-2032)
9.6 Middle East and Africa Intravenous Solutions Market by Country
9.6.1 Market Share
9.6.1.1 Saudi Arabia
9.6.1.2 United Arab Emirates
9.6.1.3 Kuwait
9.6.1.4 Algeria
9.6.1.5 Nigeria
9.6.1.6 Kenya
9.6.1.7 Morocco
9.6.1.8 South Africa
9.6.1.9 Others
10 Regional Analysis
10.1 Saudi Arabia
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 United Arab Emirates
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 Kuwait
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Algeria
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Nigeria
10.5.1 Historical Trend (2018-2023)
10.5.2 Forecast Trend (2024-2032)
10.6 Kenya
10.6.1 Historical Trend (2018-2023)
10.6.2 Forecast Trend (2024-2032)
10.7 Morocco
10.7.1 Historical Trend (2018-2023)
10.7.2 Forecast Trend (2024-2032)
10.8 South Africa
10.8.1 Historical Trend (2018-2023)
10.8.2 Forecast Trend (2024-2032)
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyer’s Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Becton, Dickinson and Company
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Fresenius Kabi South Africa (Pty) Ltd
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Well Pharma Medical Solutions LLC
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Alpha Medical Manufacturers Limited
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Intravenous Infusions Plc
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Key Trends and Developments in the Market
List of Figures and Tables
1. Global Intravenous Solutions Market: Key Industry Highlights, 2018 and 2032
2. Middle East and Africa Intravenous Solutions Market: Key Industry Highlights, 2018 and 2032
3. Middle East and Africa Intravenous Solutions Historical Market: Breakup by Product Type (USD Billion), 2018-2023
4. Middle East and Africa Intravenous Solutions Market Forecast: Breakup by Product Type (USD Billion), 2024-2032
5. Middle East and Africa Intravenous Solutions Historical Market: Breakup by Nutrients (USD Billion), 2018-2023
6. Middle East and Africa Intravenous Solutions Market Forecast: Breakup by Nutrients (USD Billion), 2024-2032
7. Middle East and Africa Intravenous Solutions Historical Market: Breakup by Country (USD Billion), 2018-2023
8. Middle East and Africa Intravenous Solutions Market Forecast: Breakup by Country (USD Billion), 2024-2032
9. Middle East and Africa Intravenous Solutions Market Structure
Key Questions Answered in the Report
The market is assessed to grow at a CAGR of 6.7% between 2024 and 2032.
The major market drivers are the expanding healthcare facilities and growing awareness about benefits of intravenous treatment.
The key market trends include increasing disposable income and the rising prevalence of malnutrition.
The major countries in the market are Saudi Arabia, the United Arab Emirates, Kuwait, Algeria, Nigeria, Kenya, Morocco, and South Africa, among others.
The various types of intravenous solutions market include partial parenteral nutrition and total parenteral nutrition.
The different nutrients in the intravenous solutions market include carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.
The major players in the Middle East and Africa intravenous solutions market are Becton, Dickinson and Company, Fresenius Kabi South Africa (Pty) Ltd, Well Pharma Medical Solutions LLC, Alpha Medical Manufacturers Limited, and Intravenous Infusions Plc, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3199
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4199
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5199
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER